Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients. Omenai SA, Ajani MA, Okolo CA. PLoS One 2022;17:e0263615.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Omenai SA, Ajani MA, Okolo CA. Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients. PLoS One 2022;17:e0263615.
PMID: 35139126